| Radiotherapy and cisplatin increase immunotherapy efficacy by enabling local and systemic intratumoral T-cell activity P Kroon, E Frijlink, V Iglesias-Guimarais, A Volkov, MM van Buuren, ... Cancer Immunology Research 7 (4), 670-682, 2019 | 44 | 2019 |
| Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells E Matas-Rico, E Frijlink, I van der Haar Àvila, A Menegakis, M van Zon, ... Cell reports 37 (7), 2021 | 43 | 2021 |
| Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples S Berendsen, E Frijlink, J Kroonen, WGM Spliet, W van Hecke, T Seute, ... Neuro-Oncology Advances 1 (1), vdz025, 2019 | 12 | 2019 |
| Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells GJJ Kierkels, E van Diest, P Hernández-López, W Scheper, ACM de Bruin, ... Molecular Therapy-Methods & Clinical Development 22, 388-400, 2021 | 7 | 2021 |
| PD-1 and CTLA-4 blockade promote CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice E Frijlink, DMT Bosma, J Busselaar, TW Battaglia, MD Staal, I Verbrugge, ... The Journal of Clinical Investigation, 2024 | | 2024 |
| Characterization and modulation of anti-abTCR antibodies and their respective binding sites at the bTCR chain to enrich engineered T cells GJJ Kierkels, E Van Diest, P Hernández-López, W Scheper, ... HUMAN GENE THERAPY 33 (7-8), A34-A34, 2022 | | 2022 |
| SP-0452 Radiotherapy and cisplatin increase immunotherapy efficacy by enabling local and systemic intratumoral T-cell activity P Kroon, E Frijlink, V Iglesias-Guimarais, A Volkov, M Van Buuren, ... Radiotherapy and Oncology 133, S235, 2019 | | 2019 |
| Select-kill strategy for untouched αβTCR-gene engineered T cell products GJJ Kierkels, W Scheper, ACM de Bruin, E Frijlink, T Aarts-Riemens, ... TCR engineered T cell therapy from concepts to clinic, 83, 2019 | | 2019 |
| P01. 10 Effects of valproic acid on NF-κB signaling in glioblastoma S Berendsen, E Frijlink, J Kroonen, WGM Spliet, W Van Hecke, T Seute, ... Neuro-Oncology 18 (Suppl 4), iv20, 2016 | | 2016 |
| Viral trafficking pathways of JC virus to the brain in Progressive Multifocal Leukoencephalopathy ES Frijlink | | 2015 |
| Partial murinization of therapeutic T cell receptors allows efficient enrichment of untouched, high-avidity TCR-engineered T cells W Scheper, E Frijlink, G Kierkels, D Sommermeyer, W Uckert, ... Cancer immunotherapy using γδT cells, 125, 2015 | | 2015 |
| PD-1 and CTLA-4 blockade promote CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer E Frijlink, DMT Bosma, TW Battaglia, J Busselaar, MD Staal, I Verbrugge, ... EVERYONE WORKS BETTER TOGETHER, 19, 0 | | |
| Effects of valproic acid on HDAC inhibition in vitro and in glioblastoma patient samples S Berendsen, E Frijlink, J Kroonen, WGM Spliet, W van Hecke, T Seute, ... PROGNOSIS IN GLIOBLASTOMA, 75, 0 | | |
